FDA Approval of ZEISS INTRABEAM 700: A Breakthrough in Cancer Surgery and Oncology
FDA Clearance of ZEISS INTRABEAM 700 for Enhanced IORT
The FDA granted 510(k) clearance to the ZEISS INTRABEAM 700, a state-of-the-art system for enhanced intraoperative radiation therapy (IORT) in cancer surgery.
Robotic-Assisted Precision in Surgical Oncology
- ZEISS INTRABEAM 700 integrates robotic precision, enhancing the efficacy of surgical oncology workflows.
- This digital-first platform allows for streamlined planning and surgical integration, providing superior data access for oncologists.
The innovative system is particularly useful in neuro-oncology and breast cancer surgeries, delivering precision that facilitates effective treatment.
Features of the ZEISS INTRABEAM 700 System
- Robotic assistance ensures optimal applicator positioning during radiation therapy.
- Active vibration damping and dynamic stabilization maintain excellent alignment for radiation delivery.
- Its advanced SMART Stand allows seamless transitions between operational modes, enhancing usability.
With this exciting advancement in cancer treatment technology, oncologists are better equipped to manage intraoperative radiation therapy effectively. Stay informed for more details on this pivotal milestone in cancer care.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.